Find en forsker – Københavns Universitet

Cardiorenal end points in a trial of aliskiren for type 2 diabetes

Research output: Contribution to journalJournal articleResearchpeer-review

Hans-Henrik Parving, Barry M Brenner, John J V McMurray, Dick de Zeeuw, Steven M Haffner, Scott D Solomon, Nish Chaturvedi, Frederik Persson, Akshay S Desai, Maria Nicolaides, Alexia Richard, Zhihua Xiang, Patrick Brunel, Marc A Pfeffer, ALTITUDE Investigators, Birger Thorsteinsson

This study was undertaken to determine whether use of the direct renin inhibitor aliskiren would reduce cardiovascular and renal events in patients with type 2 diabetes and chronic kidney disease, cardiovascular disease, or both.
Original languageEnglish
JournalNew England Journal of Medicine
Issue number23
Pages (from-to)2204-13
Number of pages10
StatePublished - 2012

ID: 48590482